18 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... Hypertension (PAH ... #Algorithm #treatment ... #pharmacology
Pulmonary Hypertension Algorithm - Matthew Watto, MD
#Diagnosis #Management #Pulmonary #Hypertension #PAH #Workup #Evaluation #Algorithm #Differential #Curbsiders
Pulmonary Hypertension ... Algorithm - Matthew ... MD #Diagnosis #Management ... #Pulmonary #Hypertension ... Workup #Evaluation #Algorithm
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... Hypertension #PAH ... #Treatment #Management
Algorithm for Diagnosis and Management of Pulmonary Hypertension

Matthew Ho, MD PhD @MatthewHoMD

#Pulmonary #Hypertension #PHTN #Algorithm #Diagnosis
Algorithm for Diagnosis ... and Management ... of Pulmonary Hypertension ... #Hypertension # ... PHTN #Algorithm
Orthostatic Hypotension Management Algorithm
 • Hypovolemic?  Yes → Resuscitate
 • Volume Overloaded? No → Fludrocortisone
Orthostatic Hypotension ... Management Algorithm ... Pyridostigmine Non-pharmacologic ... Management: • ... #Management #Algorithm
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Arterial Hypertension ... (PAH) Management ... Algorithm Dr. ... #PAH #Management ... #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Dobutamine 2-20 mcg ... Epinephrine 0-20 mcg ... Properties #Table #Pharmacology ... #Effect #Management
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... systemicsclerosis #SSc #pulmonary ... #indications #management ... #treatment #algorithm
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
of life; HTN, hypertension ... ventricular hypertrophy; MCS ... Stages #ACCAHA #Algorithm ... #Management #Cardiology
High Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH #Management #Algorithm
High Risk Pulmonary ... Arterial Hypertension ... (PAH) Management ... Algorithm Dr. ... #PAH #Management